CLNN - Clene Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.78 0.46 (5.24%) --- 0.02 (0.22%) -0.2 (-2.12%) --- 0.46 (5.24%) -0.05 (-0.58%) -0.05 (-0.58%)

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.78
Diluted EPS:
Basic P/E:
-11.8462
Diluted P/E:
RSI(14) 1m:
30.0
VWAP:
9.25
RVol:

Events

Period Kind Movement Occurred At

Related News